Monoclonal antibodies and amyloid removal as a therapeutic strategy for cardiac amyloidosis

Cardiac amyloidosis (CA) is an infiltrative disease caused by progressive deposition of amyloid fibres in the heart. The most common forms include immunoglobulin light-chain and transthyretin amyloidosis. Current therapies for CA either stabilize or block the production of amyloidogenic precursors,...

Descripción completa

Detalles Bibliográficos
Autores principales: Emdin, Michele, Morfino, Paolo, Crosta, Lucia, Aimo, Alberto, Vergaro, Giuseppe, Castiglione, Vincenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
CCC 2023 - State of the Art Cardiology Supplement Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120953/
https://www.ncbi.nlm.nih.gov/pubmed/37091656
http://dx.doi.org/10.1093/eurheartjsupp/suad079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120953/
https://www.ncbi.nlm.nih.gov/pubmed/37091656
http://dx.doi.org/10.1093/eurheartjsupp/suad079

Ejemplares similares